These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34156592)

  • 1. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: A retrospective study with external validation.
    Maurea S; Verde F; Romeo V; Stanzione A; Mainenti PP; Raia G; Barbuto L; Iacobellis F; Santangelo F; Sarno L; Migliorini S; Petretta M; D'Armiento M; De Dominicis G; Santangelo C; Guida M; Romano L; Brunetti A
    Eur J Radiol; 2023 Nov; 168():111116. PubMed ID: 37801998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US and MR imaging findings to detect placental adhesion spectrum (PAS) in patients with placenta previa: a comparative systematic study.
    Romeo V; Sarno L; Volpe A; Ginocchio MI; Esposito R; Mainenti PP; Petretta M; Liuzzi R; D'Armiento M; Martinelli P; Brunetti A; Maurea S
    Abdom Radiol (NY); 2019 Oct; 44(10):3398-3407. PubMed ID: 31435761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of magnetic resonance imaging in assessing placental adhesion disorder in patients with placenta previa: Correlation with histological findings.
    Maurea S; Romeo V; Mainenti PP; Ginocchio MI; Frauenfelder G; Verde F; Liuzzi R; D'Armiento M; Sarno L; Morlando M; Petretta M; Martinelli P; Brunetti A
    Eur J Radiol; 2018 Sep; 106():77-84. PubMed ID: 30150055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MRI-based diagnostic model for predicting placenta accreta spectrum.
    Xia J; Hu Y; Huang Z; Chen S; Huang L; Ruan Q; Zhao C; Deng S; Wang M; Zhang Y
    Magn Reson Imaging; 2024 Jun; 109():34-41. PubMed ID: 38408691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
    J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of placenta accreta spectrum by a scoring system based on maternal characteristics combined with ultrasonographic features.
    Gao Y; Gao X; Cai J; Han F; Xu G; Zhang X; Zhang T; Yu L
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1011-1017. PubMed ID: 34794730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
    Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
    Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.
    Skupski DW; Duzyj CM; Scholl J; Perez-Delboy A; Ruhstaller K; Plante LA; Hart LA; Palomares KTS; Ajemian B; Rosen T; Kinzler WL; Ananth C;
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):465-473. PubMed ID: 34725869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum.
    Jauniaux E; D'Antonio F; Bhide A; Prefumo F; Silver RM; Hussein AM; Shainker SA; Chantraine F; Alfirevic Z;
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):518-525. PubMed ID: 36609827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case series.
    Mufti N; Chappell J; O'Brien P; Attilakos G; Irzan H; Sokolska M; Narayanan P; Gaunt T; Humphries PD; Patel P; Whitby E; Jauniaux E; Hutchinson JC; Sebire NJ; Atkinson D; Kendall G; Ourselin S; Vercauteren T; David AL; Melbourne A
    Placenta; 2023 Oct; 142():36-45. PubMed ID: 37634372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on clinical characteristics and ultrasound indicators for predicting severe postpartum hemorrhage in patients with anterior placenta previa combined with previous cesarean section: a retrospective case-control study.
    Cao P; Ji L; Qiao C
    BMC Pregnancy Childbirth; 2024 Aug; 24(1):572. PubMed ID: 39217290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental thickness correlates with placenta accreta spectrum (PAS) disorder in women with placenta previa.
    Li Y; Choi HH; Goldstein R; Poder L; Jha P
    Abdom Radiol (NY); 2021 Jun; 46(6):2722-2728. PubMed ID: 33388802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal Sonographic Diagnosis and Clinical Significance of Placenta Previa Accreta after Cesarean Section.
    Liu ZZ; Wei Y; Wang RJ; Xu W; Shi ZM; Dai Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):693-698. PubMed ID: 29125114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Magnetic Resonance Imaging of the Lower Uterine Segment in Pregnant Women with Central Placenta Previa with and without Placenta Accreta Spectrum from a Single Center.
    Hou S; Song Y; Wu J; Zhou L; Kang S; Chen X; Zhang L; Lu Y; Yue Y
    Med Sci Monit; 2021 Oct; 27():e932759. PubMed ID: 34675167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.